Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

156.42 +2.47 (+1.60%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novartis AG Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
News headline image
Biogen (BIIB) Q4 Earnings Preview: The "New Biogen" Emerges as Alzheimer's and Rare Disease Pipelines Take Center Stage
Biogen Inc. (NASDAQ: BIIB) reported its fourth-quarter and full-year 2025 financial results on February 6, 2026, signaling a definitive shift from a legacy company plagued by patent cliffs to a leaner,... 
Via MarketMinute
Topics Intellectual Property
News headline image
The Era of the Titans: Q4 2025 Mega-Deal Surge and the 2026 Economic Map
As of February 6, 2026, the global financial landscape is still reverberating from a historic tectonic shift that occurred in the final months of last year. In the fourth quarter of 2025, the M&A... 
Via MarketMinute
Topics Artificial Intelligence Economy
Novartis AG-Sponsored ADR (NYSE:NVS): A Quality Dividend Stock Backed by Strong Fundamentals ↗
Via Chartmill
Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Value Investment Case ↗
Via Chartmill
News headline image
Biogen (BIIB) Deep Dive: Navigating the Pivot from MS Giant to Neuro-Innovation Powerhouse
As of February 6, 2026, Biogen Inc. (NASDAQ: BIIB) stands at a critical crossroads in its nearly 50-year history. Once the undisputed titan of the Multiple Sclerosis (MS) market, the Cambridge-based... 
Via Finterra
Topics Earnings Economy Intellectual Property
News headline image
Arrowhead (ARWR) Q1 2026 Earnings Call Transcript ↗
Arrowhead (ARWR) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Novartis (NVS) Q3 2024 Earnings Call Transcript ↗
Novartis (NVS) Q3 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Novartis Faces Biggest Patent Expiry Ever but Sees Growth Ahead ↗
Novartis AG (NVS) reported Q4 2025 results, with net sales up 1% to $13.34B, missing estimates. Generic competition and pricing impacted sales. 
Via Benzinga
Topics Intellectual Property
News headline image
Stock Market Today, Feb. 3: Novo Nordisk Slides as Pricing Pressure Clouds Obesity-Drug Outlook ↗
Novo Nordisk dropped after management forecasts weaker 2026 growth, shifting attention from recent results to pricing pressure and rising competition in obesity treatments. 
Via The Motley Fool
Topics Initial Public Offering Intellectual Property Stocks
Veteran Biopharma Engineer Ge Yang Attracts Investor Interest with Vision to Redefine Global Pharma Manufacturing
Via AB Newswire
News headline image
This Vanguard ETF Has Doubled the S&P 500's Returns Since the Start of 2025. Is It a Buy Now? ↗
It can be your key to a truly diversified portfolio. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
Peering Into Novartis AG&#39;s Recent Short Interest ↗
 
Via Benzinga
News headline image
The Biological Singularity: How AlphaFold 3 Is Rewriting the Blueprint of Drug Discovery
As of early 2026, the promise of “digital-first” drug discovery has shifted from a speculative horizon to a tangible industrial reality. Since its groundbreaking release in May 2024, AlphaFold 3... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Even Near an All-Time High, This Dividend ETF Looks Extremely Cheap ↗
There are some bargains to be found for dividend investors right now. 
Via The Motley Fool
Topics ETFs
News headline image
The Biological Singularity: How Nobel-Winning AlphaFold 3 is Rewriting the Blueprint of Life
In the annals of scientific history, few moments represent a clearer "before and after" than the arrival of AlphaFold 3. Developed by Google DeepMind and its dedicated drug-discovery arm, Isomorphic... 
Via TokenRing AI
Topics Artificial Intelligence Economy
News headline image
Lilly Bolsters Immunology Arsenal with $1.2 Billion Acquisition of Ventyx Biosciences
In a strategic move to solidify its dominance in the burgeoning field of oral anti-inflammatories, Eli Lilly and Company (NYSE:LLY) announced on January 7, 2026, a definitive agreement to acquire... 
Via MarketMinute
News headline image
The Master Architect of Molecules: How Google DeepMind’s AlphaProteo is Rewriting the Blueprint for Cancer Therapy
In the quest to cure humanity’s most devastating diseases, the bottleneck has long been the "wet lab"—the arduous, years-long process of trial and error required to find a protein that can stick to a... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Why I Am Buying the Schwab International Equity ETF (SCHF) and Never Looking Back ↗
If you're worried about U.S. stocks, you might want to load up on some international ones. This ETF makes that easy to do. 
Via The Motley Fool
Topics ETFs Economy
News headline image
The Silicon Laureates: How the 2024 Nobel Prizes Rewrote the Rules of Scientific Discovery
The year 2024 marked a historic inflection point in the history of science, as the Royal Swedish Academy of Sciences awarded Nobel Prizes in both Physics and Chemistry to pioneers of artificial... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Is This Pharmaceutical Giant a Winning Tariff-Proof Stock to Buy for 2026?
Novartis (NVS) is trading at new all-time highs on Monday. Shares are up nearly 50% over the past 52 weeks. NVS maintains a 100% “Buy” technical opinion from Barchart. Novartis has benefitted in recent... 
Via Barchart.com
Topics World Trade
News headline image
International ETFs: SPDW and SCHF Both Offer Low Cost International Exposure ↗
Explore how these two leading ETFs differ on risk, yield, and portfolio makeup—key factors for building a balanced global strategy. 
Via The Motley Fool
Topics ETFs
News headline image
VWO vs. SPDW: How Does a Emerging Markets ETF Fair Against a Developed World Fund? ↗
These two ETFs will help take your portfolio around the world, with each fund making longer pit stops in certain continents. 
Via The Motley Fool
Topics ETFs
News headline image
The Software Surge: How 2024’s $25.7 Billion M&A Explosion in Diagnostics Redefined Healthcare
The healthcare landscape underwent a seismic shift in 2024, as the industry’s major players pivoted away from traditional hardware toward high-margin diagnostic platforms and artificial intelligence... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Novartis Positions US Strategy As Defense Against Rising Trade Levies ↗
Novartis CEO says US manufacturing investments and a federal agreement could limit tariff exposure as proposed Trump levies target Europe. 
Via Benzinga
Topics Government World Trade
News headline image
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
The U.S. biotech sector has officially entered a new golden age. As of January 22, 2026, the industry is witnessing a "renaissance" that has effectively erased the memories of the grueling three-year... 
Via MarketMinute
Topics Artificial Intelligence ETFs Initial Public Offering
News headline image
The Software Stock That Could Be 2026's Biggest Surprise ↗
Palantir's top and bottom lines are both moving in the right direction. Enough investors just need to notice it again. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics
In a bold strategic opening to the 2026 fiscal year, pharmaceutical giant GSK (NYSE:GSK) has announced a definitive agreement to acquire RAPT Therapeutics (Nasdaq:RAPT) for approximately $2.2 billion.... 
Via MarketMinute
Topics Intellectual Property
News headline image
Silicon Meets Science: NVIDIA and Eli Lilly Launch $1 Billion AI Lab to Engineer the Future of Medicine
In a move that signals a paradigm shift for the pharmaceutical industry, NVIDIA (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) have announced the launch of a $1 billion joint AI co-innovation... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
International Exposure: SPDW's Lower Costs vs. URTH's U.S. Giants ↗
Explore how differences in regional focus, sector exposure, and portfolio makeup may impact your ETF investing strategy. 
Via The Motley Fool
Topics ETFs
News headline image
The Atomic Revolution: How AlphaFold 3 is Redefining the Future of Medicine
In a milestone that many researchers are calling the "biological equivalent of the moon landing," AlphaFold 3 has officially moved structural biology into a new era of predictive precision. Developed... 
Via TokenRing AI
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.